ARNA Higher After Positive Trial Results
Tweet Send to a Friend
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) is 17% higher in after-hours action ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


